29 January 2009
Predicting time to healing by anatomical assessment of venous pathology
Maria Teresa SzewczykABCDEF, Arkadiusz JawienABCDG, Arkadiusz MigdalskiB, Radoslaw PiotrowiczB, Tomasz GrzelaBC, Pawel BrazisBMed Sci Monit 2009; 15(2): CR74-81 :: ID: 869558
Abstract
Background
The aim of the study was to assess the clinical effectiveness of multilayer compression in aspect of anatomical site of venous pathology and ulcers.
Material and Method
The study was conducted between 2000 and 2006 among 112 patients with 121 ulcers treated in the Venous Ulcer Outpatient Clinic of the Chair and Clinic of Surgery, Biziel Hospital in Bydgoszcz, Poland. Patients between 31 and 89 years old (mean age - 63.6 years, median 65) were randomized into two groups treated with two- and four-layer compression system. Healing process dynamics were assessed by planimetry. Maximum period of observation was 48 weeks.
Results
The longest mean time of ulcer healing and the highest values of cumulated indicator of unhealed ulcers were observed among patients with simultaneous insufficiency of two venous systems - superficial and deep (p=0.0034, test log-rank) and among patients with insufficiency of deep, superficial and perforating venous system (p=0.0001, test log-rank). Significantly longer mean healing time was characteristic for localization on the back calf region (p=0.01, test log-rank). Dynamics of healing of ulcers treated by two- and four-layer systems were compared.
Conclusions
Anatomical localization of venous pathology and ulcer localization were found as important prognostic factors; longer healing time and lower probability of healing was observed among patients with deep venous insufficiency and when the ulcer was localized in the atypical back calf region. No differences of healing time between groups in aspect of used system were showed.
Keywords: Varicose Ulcer - therapy, Wound Healing, Time Factors, Intermittent Pneumatic Compression Devices, Aged, 80 and over
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
14 Mar 2024 : Clinical Research
Renal Dysfunction Increases Risk of Adverse Cardiovascular Events in 5-Year Follow-Up Study of Intermediate...Med Sci Monit In Press; DOI: 10.12659/MSM.943956
15 Mar 2024 : Clinical Research
Impact of One-Lung Ventilation on Oxygenation and Ventilation Time in Thoracoscopic Heart Surgery: A Compar...Med Sci Monit In Press; DOI: 10.12659/MSM.943089
14 Mar 2024 : Clinical Research
Differential DHA and EPA Levels in Women with Preterm and Term Births: A Tertiary Hospital Study in IndonesiaMed Sci Monit In Press; DOI: 10.12659/MSM.943895
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952